Form D · Biotechnology
Patient Safety Technologies, Inc
Irvine, CA · CIK 0000812301
Offering snapshot reported Jun 4, 2012 · SEC filing
- Reported sold
- $3.5M Offering amount: $3.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 18, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2012 | Initial | $3,500,000 | No comparison | 6 | SEC filing |
| Apr 12, 2011 | Initial | $7,112,500 | No comparison | 11 | SEC filing |
| Jul 7, 2010 | Initial | $6,000,000 | No comparison | 3 | SEC filing |
| Dec 2, 2009 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Aug 24, 2009 | Initial | $4,788,674 | No comparison | 45 | SEC filing |
| Aug 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-179201
Source: Form D, filed Jun 4, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard E. Chase | Director |
| David Dreyer | Executive |
| John P Francis | Director |
| Louis Glazer | Director |
| Steven H. Kane | Director, Executive |
| Herbert Langsam | Director |
| Mary Lay | Executive |
| Wenchen Lin | Director |
| Loren L. Mc Farland | Director |
| Marc Rose | Executive |
| Lynn Silverstein | Director |
| Brian E Stewart | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Venture Plaza Suite 350
Irvine, CA, 92618
Irvine, CA, 92618